FourThought Financial’s Idexx Laboratories IDXX Stock Holding History

FourThought Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$115K	Buy	354 +33	+10%	+$12.1K	0.02%	408
2022 Q2	$113K	Buy	321 +76	+31%	+$31K	0.02%	405
2022 Q1	$134K	Buy	245 +47	+24%	+$24.7K	0.02%	409
2021 Q4	$130K	Sell	198 -51	-20%	-$32K	0.02%	414
2021 Q3	$154K	Sell	249 -87	-26%	-$58.5K	0.02%	387
2021 Q2	$212K	Sell	336 -200	-37%	-$110K	0.03%	341
2021 Q1	$262K	Hold	536	–	–	0.04%	307
2020 Q4	$267K	Buy	+536	New	+$240K	0.04%	289

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

FourThought Financial's IDXX Position: Q3 2022 in Review

FourThought Financial increased its Idexx Laboratories (IDXX) stake by 10% in Q3 2022, buying an estimated $12.1K and bringing the position to 354 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #408.

FourThought Financial first reported a position in IDXX in Q4 2020 and has held it in 8 quarters since. The position peaked at $267K in Q4 2020. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

FourThought Financial held 354 shares of Idexx Laboratories worth $115K as of Q3 2022.
FourThought Financial bought 33 Idexx Laboratories shares in Q3 2022, an estimated $12.1K.
Idexx Laboratories made up 0.02% of FourThought Financial's portfolio in Q3 2022, its #408 holding.
FourThought Financial first reported a position in Idexx Laboratories in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Idexx Laboratories position peaked at $267K in Q4 2020.
925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.